Tag: Zilera Therapeutics

StaffOctober 1, 2020
zelira.jpg

5min01
Launches First-in-the-State Medical Cannabis Product  Scientifically Formulated for Autism Patients of All Ages NEW ORLEANS (LA) October 1, 2020 /AxisWire/ Louisiana-based Ilera Holistic Healthcare is pleased to announce the statewide launch of the HOPE™ line of medical cannabis tinctures based on groundbreaking scientific research on using cannabis to treat the symptoms of autism spectrum disorder […]

AxisWireApril 8, 2020
logo_zelda.jpg

10min00
Industry’s first clinically validated cannabinoid-based insomnia medication will launch globally PHILADELPHIA, April 7, 2020 /AxisWire/ Zelira Therapeutics Ltd (ASX: ZLD,OTCQB: ZLDAF), a global leader in the development of clinically validated cannabis medicines based in both Perth, Australia and Philadelphia, is pleased to announce it has received the final report for its ZTL-101 medicinal cannabis trial for […]

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.